Related Experiment Video
Updated: May 30, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
Therapeutic oligonucleotides: the road not taken
1Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA. cstein@montefiore.org
Abstract:
Antisense oligonucleotide therapeutics have been in development for almost 25 years without a single U.S. Food and Drug Administration-approved product in cancer. The reasons for this absence stem, in part, from a deep lack of understanding about how to deliver these molecules to cancer cells in vivo.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Gene Therapy
Gene Therapy
Antiviral Nucleoside Inhibitors
